TCXPRESS Trademark

Trademark Overview


On Friday, August 11, 2017, a trademark application was filed for TCXPRESS with the United States Patent and Trademark Office. The USPTO has given the TCXPRESS trademark a serial number of 87565436. The federal status of this trademark filing is REGISTERED as of Tuesday, April 7, 2020. This trademark is owned by University of Pittsburgh-Of the Commonwealth System of Higher Education. The TCXPRESS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical treatment services, namely, the administration of gene therapy to patients involving harvesting a patient's cells, cloning their T-cell receptors from single cells, screening these receptors for desired specificities such as anti-tumor or anti-minor histocompatibility antigens, transducing them into primary T-cells, and re-administration of the transduced T-cells back into the patient

Scientific research and development services for direct cloning and screening T-cell receptors from single T-cells for desired specificities such as anti-tumor or anti-minor histocompatibility antigens, and transducing them into primary T-cells for therapeutic use
tcxpress

General Information


Serial Number87565436
Word MarkTCXPRESS
Filing DateFriday, August 11, 2017
Status700 - REGISTERED
Status DateTuesday, April 7, 2020
Registration Number6029611
Registration DateTuesday, April 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements


Pseudo MarkTCX PRESS
Goods and ServicesMedical treatment services, namely, the administration of gene therapy to patients involving harvesting a patient's cells, cloning their T-cell receptors from single cells, screening these receptors for desired specificities such as anti-tumor or anti-minor histocompatibility antigens, transducing them into primary T-cells, and re-administration of the transduced T-cells back into the patient
Goods and ServicesScientific research and development services for direct cloning and screening T-cell receptors from single T-cells for desired specificities such as anti-tumor or anti-minor histocompatibility antigens, and transducing them into primary T-cells for therapeutic use

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 18, 2017
Primary Code042
First Use Anywhere DateMonday, July 29, 2019
First Use In Commerce DateMonday, July 29, 2019

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 18, 2017
Primary Code044
First Use Anywhere DateMonday, July 29, 2019
First Use In Commerce DateMonday, July 29, 2019

Trademark Owner History


Party NameUniversity of Pittsburgh-Of the Commonwealth System of Higher Education
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPittsburgh, PA 15260

Party NameUniversity of Pittsburgh-Of the Commonwealth System of Higher Education
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPittsburgh, PA 15260

Party NameUniversity of Pittsburgh-Of the Commonwealth System of Higher Education
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPittsburgh, PA 15260

Trademark Events


Event DateEvent Description
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017NEW APPLICATION ENTERED
Friday, August 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 14, 2017ASSIGNED TO EXAMINER
Thursday, November 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2018SOU EXTENSION 1 FILED
Wednesday, July 11, 2018SOU EXTENSION 1 GRANTED
Tuesday, January 29, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 11, 2018SOU TEAS EXTENSION RECEIVED
Friday, July 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 26, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 26, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 1, 2019SOU EXTENSION 3 FILED
Tuesday, January 29, 2019SOU EXTENSION 2 FILED
Tuesday, January 29, 2019SOU EXTENSION 2 GRANTED
Thursday, January 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 30, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 1, 2019SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2019SOU EXTENSION 3 GRANTED
Monday, February 10, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, August 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 5, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 7, 2020REGISTERED-PRINCIPAL REGISTER
Friday, February 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 10, 2020USE AMENDMENT FILED
Tuesday, March 3, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 4, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 7, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED